Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Acyclovir-Loaded Solid Lipid Nanoparticles: Optimization, Characterization And Evaluation Of Its Pharmacokinetic Profile
Haniza Hassan, R. O. Bello, S. K. Adam, Ekram Alias, M. M. R. Meor Mohd Affandi, A. Shamsuddin, Rusliza Basir
Published 2020 · Chemistry, Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Acyclovir is an antiviral drug used for the treatment of herpes simplex virus infection. Its oral bioavailability is low; therefore, frequent and high doses are prescribed for optimum therapeutic efficacy. Moreover, the current therapeutic regimen of acyclovir is associated with unwarranted adverse effects, hence prompting the need for a suitable drug carrier to overcome these limitations. This study aimed to develop solid lipid nanoparticles (SLNs) as acyclovir carriers and evaluate their in vivo pharmacokinetic parameters to prove the study hypothesis. During the SLN development process, response surface methodology was exploited to optimize the composition of solid lipid and surfactant. Optimum combination of Biogapress Vegetal 297 ATO and Tween 80 was found essential to produce SLNs of 134 nm. The oral bioavailability study showed that acyclovir-loaded SLNs possessed superior oral bioavailability when compared with the commercial acyclovir suspension. The plasma concentration of acyclovir-loaded SLNs was four-fold higher than the commercial suspension. Thus, this investigation presented promising results that the method developed for encapsulation of acyclovir offers potential as an alternative pathway to enhance the drug’s bioavailability. In conclusion, this study exhibited the feasibility of SLNs as an oral delivery vehicle for acyclovir and therefore represents a new promising therapeutic concept of acyclovir treatment via a nanoparticulate drug delivery system.
This paper references
Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3
Te Du (2013)
Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability
A. Neves (2013)
Simvastatin Solid Lipid Nanoparticles for Oral Delivery: Formulation Development and In vivo Evaluation
S. G. Padhye (2013)
Pharmacokinetics of acyclovir suspension in infants and children.
W. Sullender (1987)
20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications.
R. Mueller (2011)
Oral insulin delivery by means of solid lipid nanoparticles
B. Sarmento (2007)
Preparation and characterization of n-dodecyl-ferulate-loaded solid lipid nanoparticles (SLN).
E. Souto (2005)
Development and in vivo evaluation of an innovative "Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles" formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics.
M. Cirri (2017)
Advanced drug delivery to the lymphatic system: lipid-based nanoformulations
A. Khan (2013)
Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin.
V. Kakkar (2011)
Design and development of multivesicular liposomal depot delivery system for controlled systemic delivery of acyclovir sodium
S. Jain (2008)
Proteomic Characterization of Acyclovir-Induced Nephrotoxicity in a Mouse Model
H. Lu (2014)
Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins
Ching-Yun Hsu (2019)
Herpes simplex virus: Global infection prevalence and incidence estimates
C James (2016)
Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function
J. Smith (2009)
Formulation Optimization of a Palm-Based Nanoemulsion System Containing Levodopa
Syafinaz Zainol (2012)
Solid Lipid Nanoparticles of Atovaquone Based on 24 Full-Factorial Design. Iran
N. Mohtar (2015)
Polydispersity index and molecular weight distributions of polymers
M. Rogošić (1996)
Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation
Mounika Nooli (2017)
A randomized, double-blind, comparative trial comparing high- and standard-dose oral acyclovir for first-episode genital herpes infections.
A. Wald (1994)
Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles
K. Vivek (2008)
Beta-carotene-Encapsulated Solid Lipid Nanoparticles (BC-SLNs) as Promising Vehicle for Cancer: an Investigative Assessment
Ashay Jain (2019)
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
K. J. Looker (2015)
Herpes simplex virus type 1 infections.
J. Cather (1998)
Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery
P. Severino (2012)
Formulation and optimization of solid lipid nanoparticle formulation for pulmonary delivery of budesonide using Taguchi and Box-Behnken design
J. Emami (2015)
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
L. Hu (2004)
Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes.
Y. Shono (2004)
Antiviral Drugs and Acute Kidney Injury (AKI).
Wattana Leowattana (2019)
Current Antivirals and Novel Botanical Molecules Interfering With Herpes Simplex Virus Infection
D. M. Álvarez (2020)
Beijing Da Xue Xue Bao Yi Xue Ban
Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012
K. J. Looker (2015)
Solid Lipid Nanoparticles of Atovaquone Based on 24 Full-Factorial Design
N. Mohtar (2015)
Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery.
Kuldeep Rajpoot (2019)
Intestinal efflux transporters and drug absorption.
T. Murakami (2008)
Development and In Vitro-In Vivo Evaluation of Oral Drug Delivery System of Acyclovir Loaded PLGA nanoparticles.
U. V. Bhosale (2013)
Oral acyclovir induced hypokalemia and acute tubular necrosis a case report
J. Chávez-Iñiguez (2018)
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound.
A. Silva (2011)
Human herpes simplex virus: Life cycle and development of inhibitors
M. Kukhanova (2014)
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
C. James (2020)
Effect of Solid Lipid Nanoparticles Formulation Compositions on Their Size, Zeta Potential and Potential for In Vitro pHIS-HIV-Hugag Transfection
Rathapon Asasutjarit (2007)
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin
Hongyu Ji (2016)
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
[Effect of quercetin on the acyclovir intestinal absorption].
Z. Yang (2004)
Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
T. Palmberger (2008)
Preparation and in vitro-in vivo evaluation of acyclovir floating tablets
R. Bahri-Najafi (2017)
Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats
H. Zhang (2003)
20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications
R. Mueller (2011)
Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases
P. Ganesan (2018)
Acyclovir Nephrotoxicity: A Case Report Highlighting the Importance of Prevention, Detection, and Treatment of Acyclovir-Induced Nephropathy
R. Fleischer (2010)
Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
C. Lin (2017)
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
H. Harde (2011)
Physicochemical investigations on the structure of drug-free and drug-loaded solid lipid nanoparticles (SLN) by means of DSC and 1H NMR.
E. Zimmermann (2005)
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers
A. Parr (2015)
Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats.
L. Shi (2016)
Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction
K. Westesen (1993)
Effect of Surfactant Concentration on the Particle Size, Stability and Potential Zeta of Beta carotene Nano Lipid Carrier
M. Zirak (2002)
Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery.
Rishi Paliwal (2009)
Crystal-induced acute renal failure.
M. Perazella (1999)
Destabilization Mechanism of Ionic Surfactant on Curcumin Nanocrystal against Electrolytes
H. Rachmawati (2016)